Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 3 opinions in the last 12 months.
Quipt Home Medical, symbol QIPT-X, has garnered mixed reviews from industry experts. The CEO is recognized for being a capable operator, yet the stock struggles to gain attention from investors despite respectable EBITDA figures driven by equipment depreciation. The overall growth narrative appears stagnant, prompting concerns about its long-term potential, especially in an environment where healthcare innovations are impacting traditional sectors. While some experts note that the company operates well within the aging healthcare demographic, they also emphasize potential headwinds, such as competition from weight loss drugs that might diminish respiratory care needs. Valuation remains low compared to historical standards, reflecting cautious investor sentiment amid ongoing scrutiny regarding advertising practices.
Extremely challenged, though business continues to do well. One headwind is weight loss drug success makes investors concerned that respiratory issues will go away. That won't happen. Advertising practices under scrutiny, and there could be a fine.
Numbers continue to grow. Valuation lower than historically.
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Company recently acquired (Great Elm). At $80M it is a sizeable deal, but adds $60M in revenue and $13M in EBITDA. Should be $2M in cost savings and it is accretive to cash flow. The market likes the deal. Good earnings growth is expected. Unlock Premium - Try 5i Free
Quipt Home Medical is a Canadian stock, trading under the symbol QIPT-X on the TSX Venture Exchange (QIPT-CV). It is usually referred to as TSXV:QIPT or QIPT-X
In the last year, 3 stock analysts published opinions about QIPT-X. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Quipt Home Medical.
Quipt Home Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Quipt Home Medical.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Quipt Home Medical In the last year. It is a trending stock that is worth watching.
On 2023-06-20, Quipt Home Medical (QIPT-X) stock closed at a price of $7.28.
CEO is a really good operator, but stock just doesn't seem to get any love. Numbers have been OK, but not any really great growth. Looks good on EBITDA (due to equipment depreciation), but not on earnings. Takeout rumours always swirl but he won't buy on that basis alone, praying for a takout, if the fundamentals aren't there.
The trend of keeping people out of hospitals sounds good, but he's a numbers guy and it doesn't have the growth he wants.